The Norwegian Vitamin Trial (NORVIT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT00266487

Recruitment Status : Completed

First Posted : December 16, 2005

Last Update Posted : May 8, 2017

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborators:

The Research Council of Norway

The Council on Health and Rehabilitation, Norway

The Norwegian Council on Cardiovascular Disease

The Royal Norwegian Ministry of Health

The International Federation of Red Cross and Red Crescent Societies

Foundation to Promote Research into Functional Vitamin B12 Deficiency, Bergen, Norway

Information provided by:

University of Tromso

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Primary Completion Date :	No date given
Study Completion Date :	March 2004

Publications of Results:

Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K; NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006 Apr 13;354(15):1578-88. doi: 10.1056/NEJMoa055227. Epub 2006 Mar 12.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Dhar I, Lysne V, Svingen GFT, Ueland PM, Gregory JF, Bonaa KH, Nygard OK. Elevated plasma cystathionine is associated with increased risk of mortality among patients with suspected or established coronary heart disease. Am J Clin Nutr. 2019 Jun 1;109(6):1546-1554. doi: 10.1093/ajcn/nqy391.

To Top